Company Overview
Snapshot
Founded in December 2019 by Eran Eshed and Dr. Assaf Ben-Meir, Fairtility operates with 11–50 employees. The company has raised $18.5M across 3 funding rounds from 3 investors.
Business overview
Fairtility is a Health Tech & Life Sciences company that leverages artificial intelligence to enhance in vitro fertilization (IVF) outcomes. Its core product, CHLOE (Cultivating Human Life through Optimal Embryos), is a transparent AI-based decision support tool designed to provide clinicians with comprehensive visibility into clinical and laboratory parameters. This technology aims to reduce the number of IVF cycles required for a live birth, thereby minimizing the emotional, physical, and financial burden on prospective parents. Fairtility serves the digital healthcare market, focusing on fertility and women's health, with applications spanning from infertility cause assessment to transfer optimization.
Strategic signal
In April 2022, Fairtility's AI-trained embryo labeling technique was highlighted for boosting IVF success rates. This signals a significant advancement in fertility treatment, demonstrating the company's capability to apply artificial intelligence to improve clinical outcomes and potentially redefine standards in reproductive medicine, offering a strong validation of their technology for investors and innovation teams.
Log in to access full profile ›Company Intelligence Q&A
- What is Fairtility's primary focus?
- Fairtility focuses on powering in vitro fertilization (IVF) through transparent artificial intelligence to improve outcomes and reduce the number of IVF cycles needed for a live birth.
- Who founded Fairtility?
- Fairtility was co-founded by Eran Eshed and Dr. Assaf Ben-Meir in December 2019.
- What is CHLOE?
- CHLOE (Cultivating Human Life through Optimal Embryos) is Fairtility's transparent AI-based decision support tool designed to provide clinicians with complete visibility into clinical and laboratory parameters to help improve IVF outcomes.
- What was a key development for Fairtility in April 2022?
- In April 2022, an AI-trained embryo labeling technique developed by Fairtility was recognized for its ability to boost IVF success rates.